Bamlanivimab Efficacy in Older and High-BMI Outpatients With COVID-19 Selected for Treatment in a Lottery-Based Allocation Process.

Rubin, Emily B; Boiarsky, Jonathan A; Canha, Lauren A; Giobbie-Hurder, Anita; Liu, Mofei; Townsend, Matthew J; Dougan, Michael

Rubin, Emily B; Boiarsky, Jonathan A; Canha, Lauren A; Giobbie-Hurder, Anita; Liu, Mofei; Townsend, Matthew J; Dougan, Michael.

Afiliação

Rubin EB; Division of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Boiarsky JA; University of California, Los Angeles Medical Center, Los Angeles, California, USA.
Canha LA; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Giobbie-Hurder A; Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Liu M; Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Townsend MJ; Duke University Medical Center, Durham, North Carolina, USA.
Dougan M; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

Open Forum Infect Dis ; 8(12): ofab546, 2021 Dec.

Article em En | MEDLINE | ID: mdl-34888396

Palavras-chave

COVID-19; monoclonal antibodies

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google